However, the specific mechanisms of glucagon signaling dysregulation in NAFLD require further investigation, particularly its precise role in hepatic lipid metabolism and inflammatory responses. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.